Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease

NCT ID: NCT03743311

Last Updated: 2021-03-29

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1032 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-01

Study Completion Date

2019-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The program is aimed at obtaining data on the impact of the method and type of treatment on the quality of life of patients with acute or chronic hemorrhoids with option of conservative treatment with Detralex

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Changes in the quality of life of patients suffering from acute or chronic hemorrhoids within 1 month after presenting to a doctor, in general population and in specific demographic and clinical groups.

The program included patients who presented to a doctor for acute or chronic hemorrhoids. All the treatment was fully compliant with the conventional clinical practice, instructions for medical use of drugs and a specific clinical situation. The standard parameters usually evaluated in patients with hemorrhoids were studied during the program. In addition, at the first visit to the doctor and at the end of the study, the patient filled out an SF-36 questionnaire for assessing the QoL

The general population of patients included in the program, the following three groups of patients were considered:

* Group 1, with only conservative (medical) therapy during the study;
* Group 2, with conservative (medical) therapy and additional minimally invasive procedure during the study (no surgery);
* Group 3, with conservative (medical) therapy and additional surgery for hemorrhoids during the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemorrhoids

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical treatment of Hemmorhoid

Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.)

Hemorrhoidectomy, Thrombectomy , Operation on Longo method

Intervention Type PROCEDURE

Surgical procedures for treatment of Hemorhoid

Conservative treatment of Hemmorhoid

Patients taken conservative treatment (Detralex)

Detralex

Intervention Type DRUG

Conservative treatment of Hemorhoid

Combined treatment of Hemmorhoid

Combined treatment patients (surgery and conservative treatment)

Combined therapy

Intervention Type OTHER

Surgical + conservative treatment of Hemorhoid

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hemorrhoidectomy, Thrombectomy , Operation on Longo method

Surgical procedures for treatment of Hemorhoid

Intervention Type PROCEDURE

Detralex

Conservative treatment of Hemorhoid

Intervention Type DRUG

Combined therapy

Surgical + conservative treatment of Hemorhoid

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age over 18 years;
2. Providing written information to a patient about inclusion in the program, and his/her consent to participate in it,
3. Absence of conditions requiring urgent medical care and not related to hemorrhoids;
4. The patient was diagnosed with:

* Acute hemorrhoids;
* Exacerbation of chronic hemorrhoids;
* Chronic hemorrhoids

Exclusion Criteria

1. The patient is consulting for an urgent issue not related to hemorrhoids;
2. The presence of severe systemic diseases;
3. Pregnancy;
4. Inability to understand the meaning of the Program and follow the doctor's recommendations
5. Patients with inflammatory bowel diseases
6. Patients with concomitant diseases of the anal canal
7. Patients taking anticoagulants;
8. Patients with previous anorectal surgeries, including hemorrhoidectomy or excision of anal fistula.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Servier Russia

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olga LINNIK

Role: STUDY_CHAIR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pirogov National Surgery Center

Moscow, Pervomaisrfya 70, Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Russia

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: the SF36 scale questioner

The scale the SF36 scale questioner can be sent by email.

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IC4 -05682-058-RUS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Complex Treatment of a Chronic Anal Fissure
NCT03855046 RECRUITING PHASE4